Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for uracil root_notes_note in Note (approximate match)

Showing 31 - 31 of 31 results

First page
Previous page
4
Next page disabled
Next page disabled

COLA ACUMINATA SEED

1F8VIW1479

Status:

Possibly Marketed Outside US

Source:

M006

(2020)

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=261223c6-6d2d-4c9d-90c9-a2ac3d3da07e

First approved in 2010

Source:

21 CFR 333D

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a4df7094-3319-4ee3-84ae-ff12fafbd6a8

Class:

STRUCTURALLY DIVERSE

Structurally Diverse

COLA ACUMINATA SEED

Showing 31 - 31 of 31 results

First page
Previous page
4
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1